David Roth - Apr 1, 2022 Form 4 Insider Report for Syros Pharmaceuticals, Inc. (SYRS)

Role
Chief Medical Officer
Signature
/s/ David A. Roth
Stock symbol
SYRS
Transactions as of
Apr 1, 2022
Transactions value $
-$30,555
Form type
4
Date filed
4/4/2022, 05:03 PM
Previous filing
Feb 17, 2022
Next filing
Jul 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SYRS Common Stock Tax liability -$30.6K -27.3K -31.36% $1.12 59.7K Apr 1, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares used to cover tax withholding on a Restricted Stock Unit release.